Oral N-acetylcysteine as an adjunct to standard medical therapy improved heart function in cases with stable class II and III systolic heart failure
ConclusionsThese preliminary data support experimental findings showing that NAC supplementation is able to improve heart function.Trial registrationThe registration of the trial was done at the Iranian Registry of Clinical Trials (www.irct.ir). Identifier code: IRCT20120215009014N333. Registration date: 2020 –01-11.
Source: Irish Journal of Medical Science - Category: General Medicine Source Type: research
More News: Acetylcysteine | Biomedical Science | Cardiology | Clinical Trials | General Medicine | Heart | Heart Failure | Iran Health | Ireland Health | Science | Study